Skip to main content
HSICHenry Schein, Inc.Sell5.4·$90.30-0.62%

Henry Schein (HSIC) Q2 2026 earnings — TrendMatrix coverage

BEAT+2.5% vs estimateEPS $1.27 vs $1.24 estVerdict HoldBuy (Wait)

Reported

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure

Event detail · Q2 2026

Key numbers

Reported EPS
$1.27
Estimate
$1.24
Surprise
+2.5%
Revenue (period 2026-06-27)
$3.46B
Score at report (before → after)
5.15.1/10

Revenue source: xbrl.

Report record · Q2 2026

How the report landed

Henry Schein (HSIC) beat the $1.24 estimate with diluted EPS of $1.27 — a modest 2.5% upside surprise. TrendMatrix's engine moved from Hold (5.1/10) to Buy (Wait) at 5.1/10 after the report.

Current read · as of 2026-09-04

Where TrendMatrix's rating stands now

TrendMatrix currently rates HSIC Sell at 5.4/10.

4 of the last 4 quarters beat the estimate; this quarter's +2.5% surprise compares with a +5.6% four-quarter average. Next scheduled report: 2026-11-03.

What supports the rating

  • Sector modifier (Healthcare): +0.5
  • Strong earnings beat streak (4/4)

What argues against it

  • Analyst target reached - limited upside remaining
  • Near 52-week high (2.1% away)
  • V7 low-quality RISK_OFF penalty: -0.5 (Q=4.1)

This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.

Current engine read

The levels TrendMatrix's engine tracks

Current price
$90.30
Price target
$103.76
Stop
$86.84
Upside to target
+14.9%

The stock trades at 26.4× trailing but 15.1× forward earnings — consensus estimates already build in a substantial earnings recovery.

Model outputs from TrendMatrix’s engine as of 2026-09-04 — shown for context, not personalized investment advice.

Healthcare context

HSIC at TrendMatrix's latest read

Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.

Industry
Medical Distribution
Market cap
$10.13B
P/E (fwd)
15.1
P/E (ttm)
26.4
52-week range
$61.95$92.18
Off 52-week high
2.0%
RSI (14)
54
Volume vs avg
0.32×
Score today
5.4/10

Earnings figures are sourced from TrendMatrix’s pipeline (EPS: existing earnings extraction; revenue: SEC XBRL company facts where available, yfinance-provisional otherwise). Not a buy/sell rating, a price target, or investment advice — see the current verdict on the stock’s main page for TrendMatrix’s live read.

Home Stocks HSIC Earnings Q2 2026 earnings